Pneumococcal conjugate second or third-dose vaccines (PCVc) in Eritrea
Eritrea: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 96.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Eritrea, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Eritrea stood at 96.0%. That is the highest value across all 18 years on record.
The figure is up 1.1% on the previous year and up 1.1% over five years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Eritrea peaked at 96.0% in 2025 and was at its lowest, 0.0%, in 2008.
Eritrea ranks 27th of 194 countries on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Eritrea, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 95.0% | — |
| 2017 | 95.0% | +0.0% |
| 2018 | 95.0% | +0.0% |
| 2019 | 95.0% | +0.0% |
| 2020 | 95.0% | +0.0% |
| 2021 | 95.0% | +0.0% |
| 2022 | 95.0% | +0.0% |
| 2023 | 95.0% | +0.0% |
| 2024 | 95.0% | +0.0% |
| 2025 | 96.0% | +1.1% |
Eritrea compared with similar countries
- Eritrea's 96.0% is above the median for low income countries, which is 80.0%, 1.2× the median. (25 countries reporting)
- Eritrea's 96.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 38.0% | 0.0% | 95.0% | 10 |
| 2020s | 95.2% | 95.0% | 96.0% | 6 |
Countries ranked near Eritrea
More health data for Eritrea
- Un projection of annual infant deaths, annual growth rate -1.62 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.2 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 821.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 425 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2011)
- Population ages 00-04, female, per capita 0.0652 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.73 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2011)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Eritrea?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Eritrea was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Eritrea?
- The highest recorded value was 96.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Eritrea?
- The lowest recorded value was 0.0% in 2008.
- How does Eritrea rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Eritrea ranks 27th out of 194 countries with data for 2025.
- Where does this Eritrea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).